KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Assets: 2017-2025

Historic Assets for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $13.6 billion.

  • Elanco Animal Health's Assets rose 2.02% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 billion, marking a year-over-year increase of 2.02%. This contributed to the annual value of $12.6 billion for FY2024, which is 12.17% down from last year.
  • As of Q3 2025, Elanco Animal Health's Assets stood at $13.6 billion, which was down 1.39% from $13.7 billion recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Assets peaked at $17.0 billion during Q1 2021, and registered a low of $12.6 billion during Q4 2024.
  • Its 3-year average for Assets is $14.0 billion, with a median of $13.8 billion in 2024.
  • Its Assets has fluctuated over the past 5 years, first surged by 74.64% in 2021, then dropped by 12.86% in 2024.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Assets stood at $16.5 billion in 2021, then decreased by 5.99% to $15.5 billion in 2022, then fell by 7.29% to $14.4 billion in 2023, then decreased by 12.17% to $12.6 billion in 2024, then rose by 2.02% to $13.6 billion in 2025.
  • Its last three reported values are $13.6 billion in Q3 2025, $13.7 billion for Q2 2025, and $12.9 billion during Q1 2025.